Delivery Order SPE2DB24D3013-SPE2DB26FFGEY
Award Date 11/6/25
Potential Completion Date 11/7/25
Potential Value $5.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,636.97 delivery order to AmerisourceBergen Drug Corp for Xultophy 100 Unit-3.6mg/mL pens (3mL quantity) with a completion date of July 29, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,414.62 firm fixed price contract is for the delivery of XULTOPHY 100 UNIT-3.6MG/ML PEN 3ML, a pharmaceutical product. The delivery order has an ultimate completion date of April 4, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and this order is part of a larger indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $6,895.09, is for the delivery of XULTOPHY 100 UNIT-3.6MG/ML PEN 3ML, a medical product. This is a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of April 10, 2025. The award is not designated with a set-aside requirement, indicating...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,047.05 firm fixed-price delivery order is for the supply of XULTOPHY 100 UNIT-3.6MG/ML PEN 3ML, a specialty pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is for the delivery order SPE2DB22D2206|SPE2DB24FGU37 to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $3,164.88 Firm Fixed Price contract is for the delivery of XULTOPHY 100 UNIT-3.6MG/ML PEN 3ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 8, 2025, for the supply of Insulin Lispro 100 Unit/ML pens (3ML) with a ceiling value of $1,358.28. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025, and is being funded through the Medical Supply Chain, a defense-oriented federal agency. The contract represents a child delivery order under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Medical Supply Chain (a component of the Department of Defense) on September 11, 2025, for NovoLog Mix 70-30 FlexPen 3mL insulin pens. This firm fixed-price delivery order, valued at $4,500.30, represents a non-competitive set-aside contract with an ultimate completion date of September 12, 2025. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,259.60 delivery order on October 23, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens, with completion scheduled for October 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10 mL) with a ceiling value of $1,463.20. This is a firm fixed price delivery order with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,463.20 for Insulin Aspart 100 Unit/mL vials (10mL) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's existing Indefinite...